BofA raised the firm’s price target on Eastman Chemical (EMN) to $112 from $109 and keeps a Buy rating on the shares. Eastman continues to deliver “solid” earnings and volume growth, which the analyst says is in contrast to the majority of his chemicals coverage universe. The firm sees capital deployment into buybacks and/or bolt-on M&A providing additional upside in the next few years, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMN:
- Eastman Chemical price target raised to $128 from $121 at KeyBanc
- Eastman Chemical price target lowered to $108 from $111 at Barclays
- Eastman Chemical’s Earnings Call Highlights Balanced Performance
- Eastman Chemical Reports Strong 2024 Results
- Early notable gainers among liquid option names on January 31st